Sort by
Items per page

Send to

Choose Destination

Best matches for cardiovascular disease AND diabetes mellitus AND microvascular complications AND risk factors:

Search results

Items: 1 to 20 of 1287


Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications.

Leustean AM, Ciocoiu M, Sava A, Costea CF, Floria M, Tarniceriu CC, Tanase DM.

J Diabetes Res. 2018 Nov 12;2018:5205126. doi: 10.1155/2018/5205126. eCollection 2018. Review.


Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.

Borghetti G, von Lewinski D, Eaton DM, Sourij H, Houser SR, Wallner M.

Front Physiol. 2018 Oct 30;9:1514. doi: 10.3389/fphys.2018.01514. eCollection 2018. Review.


[Frequency and associated risk factors of cardiovascular autonomic neuropathy among patients with type 2 Diabetes.]

Romero SA, Ortin A, Mercado N, Caeiro G, Waitman J.

Rev Fac Cien Med Univ Nac Cordoba. 2018 Jun 29;75(2):111-118. doi: 10.31053/1853.0605.v75.n2.17566. Spanish.


A study on the glycemic, lipid and blood pressure control among the type 2 diabetes patients of north Kerala, India.

Kumar SP, Sandhya AM.

Indian Heart J. 2018 Jul - Aug;70(4):482-485. doi: 10.1016/j.ihj.2017.10.007. Epub 2017 Oct 12.


Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients.

Moţăţăianu A, Maier S, Bajko Z, Voidazan S, Bălaşa R, Stoian A.

BMC Neurol. 2018 Aug 27;18(1):126. doi: 10.1186/s12883-018-1125-1.


Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes.

Magri CJ, Mintoff D, Camilleri L, Xuereb RG, Galea J, Fava S.

J Diabetes Res. 2018 Jul 22;2018:7464320. doi: 10.1155/2018/7464320. eCollection 2018.


Risk Factors for Microvascular Complications of Diabetes in a High-Risk Middle East Population.

Cheema S, Maisonneuve P, Zirie M, Jayyousi A, Alrouh H, Abraham A, Al-Samraye S, Mahfoud Z, Al-Janahi IM, Ibrahim B, Lowenfels AB, Mamtani R.

J Diabetes Res. 2018 Jul 2;2018:8964027. doi: 10.1155/2018/8964027. eCollection 2018.


Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.

Zghebi SS, Rutter MK, Ashcroft DM, Salisbury C, Mallen C, Chew-Graham CA, Reeves D, van Marwijk H, Qureshi N, Weng S, Peek N, Planner C, Nowakowska M, Mamas M, Kontopantelis E.

BMJ Open. 2018 Jun 30;8(6):e020926. doi: 10.1136/bmjopen-2017-020926.


Prevalence of Chronic Complications, Their Risk Factors, and the Cardiovascular Risk Factors among Patients with Type 2 Diabetes Attending the Diabetic Clinic at a Tertiary Care Hospital in Sri Lanka.

Arambewela MH, Somasundaram NP, Jayasekara HBPR, Kumbukage MP, Jayasena PMS, Chandrasekara CMPH, Fernando KRAS, Kusumsiri DP.

J Diabetes Res. 2018 May 23;2018:4504287. doi: 10.1155/2018/4504287. eCollection 2018.


Social Network Characteristics Are Associated With Type 2 Diabetes Complications: The Maastricht Study.

Brinkhues S, Dukers-Muijrers NHTM, Hoebe CJPA, van der Kallen CJH, Koster A, Henry RMA, Stehouwer CDA, Savelkoul PHM, Schaper NC, Schram MT.

Diabetes Care. 2018 Aug;41(8):1654-1662. doi: 10.2337/dc17-2144. Epub 2018 Jun 15.


[Factors associated with quality of life related to health in persons with Diabetes Mellitus of the University Social Work of Cordoba].

López AC, Cecchetto E, Aguirre AN, Ontiveros MC, Roitter CV, Garcia AJ, Bernet J, Aguirre JA.

Rev Fac Cien Med Univ Nac Cordoba. 2017 Dec 21;74(4):306-312. Spanish.


Microangiopathy is associated with bone loss in female type 2 diabetes mellitus patients.

Zhong N, Zhang Y, Pu X, Xu B, Xu M, Cai H, Zhang G, Cui R, Sheng H, Qu S.

Diab Vasc Dis Res. 2018 Sep;15(5):433-441. doi: 10.1177/1479164118779386. Epub 2018 Jun 12.


The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications.

Wong NKP, Nicholls SJ, Tan JTM, Bursill CA.

Int J Mol Sci. 2018 Jun 5;19(6). pii: E1680. doi: 10.3390/ijms19061680. Review.


Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.

Knapp M, Tu X, Wu R.

Acta Pharmacol Sin. 2018 Jun 4. doi: 10.1038/s41401-018-0042-6. [Epub ahead of print] Review.


Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints.

Doumas M, Imprialos Κ, Stavropoulos K, Reklou A, Sachinidis A, Athyros VG.

Curr Pharm Des. 2018;24(17):1879-1886. doi: 10.2174/1381612824666180604113653.


The Constellation of Macrovascular Risk Factors in Early Onset T2DM: A Cross-Sectional Study in Xinjiang Province, China.

Zhang M, Mao J, Tuerdi A, Zeng X, Quan L, Xiao S, Zhu J, Yao H.

J Diabetes Res. 2018 Apr 3;2018:3089317. doi: 10.1155/2018/3089317. eCollection 2018.


Diabetic Ulcer.

Packer CF, Manna B.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.


Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.

Welsh P, Rankin N, Li Q, Mark PB, Würtz P, Ala-Korpela M, Marre M, Poulter N, Hamet P, Chalmers J, Woodward M, Sattar N.

Diabetologia. 2018 Jul;61(7):1581-1591. doi: 10.1007/s00125-018-4619-x. Epub 2018 May 4.


Angiopoietin-2 level as a tool for cardiovascular risk stratification in hypertensive type 2 diabetic subjects.

Siddiqui K, Joy SS, Nawaz SS, Al Otaibi MT, Al-Rubeaan K.

Postgrad Med. 2018 May;130(4):402-408. doi: 10.1080/00325481.2018.1469370. Epub 2018 May 8.


Supplemental Content

Loading ...
Support Center